Trump administration plans to allow prescription drug imports from Canada
In a move to fulfill a 2016 campaign promise, the Trump administration is planning to create a way for Americans to legally import prescription drugs from Canada.
This week’s announcement, from the Department of Health and Human Services, comes after years of push-back from health care authorities and pleas from the public for affordable medications
Health and Human Services Secretary Alex Azar says there are two pathways for the plan. One options would allow individual states to draft their own plans to import the drugs. In the other, the FDA would establish guidelines for drug manufacturers.
“What we’re talking about are the same drugs that Canadian citizens have access to in Canadian cities,” said Azar. “We’re working through businesses and the states to get them brought into the U.S in a way that respects and controls their safety and complies with the FDA’s regular requirements.”
Critics say the plan is too dangerous, claiming there is no way to guarantee the safety of drugs that come into the country.
President and CEO Stephen J. Ubl of PhRMA, a trade group representing U.S pharmaceutical companies, released the following statement: